Accounts in drug discovery [electronic resource] : case studies in medicinal chemistry / [edited by] Joel Barrish, Percy Carter, Robert Zahler.
Accounts in Drug Discovery describes recent case studies in medicinal chemistry with a particular emphasis on how the inevitable problems that arise during any project can be surmounted or overcome. The Editors cover a wide range of therapeutic areas and medicinal chemistry strategies, including lea...
Saved in:
Online Access: |
Full Text (via RSC) |
---|---|
Other Authors: | , , |
Format: | Electronic eBook |
Language: | English |
Published: |
Cambridge :
Royal Society of Chemistry,
[2010], ©2011.
|
Series: | RSC drug discovery series ;
4. |
Subjects: |
MARC
LEADER | 00000cam a2200000xa 4500 | ||
---|---|---|---|
001 | b12159193 | ||
003 | CoU | ||
005 | 20250117033837.5 | ||
006 | m o d | ||
007 | cr ||||||||||| | ||
008 | 100621t20102011enk o 000 0 eng d | ||
019 | |a 904191583 | ||
020 | |a 9781849731980 |q (electronic bk.) | ||
020 | |a 1849731985 |q (electronic bk.) | ||
020 | |z 9781849731263 | ||
020 | |z 1849731268 | ||
024 | 7 | |a 10.1039/9781849731980 | |
035 | |a (OCoLC)rsc642690086 | ||
035 | |a (OCoLC)642690086 |z (OCoLC)904191583 | ||
037 | |a rsc9781849731980 | ||
040 | |a UKRSC |b eng |e pn |c UKRSC |d CUS |d OCLCQ |d E7B |d YDXCP |d N$T |d MHW |d OCLCF |d AZU |d OCLCQ |d AGLDB |d DEBSZ |d OCLCQ |d VTS |d NLE |d STF |d LEAUB |d M8D |d OCLCQ |d AJS |d OCLCQ |d OCLCO |d OCLCQ | ||
049 | |a GWRE | ||
050 | 4 | |a RM301.25 |b .A23 2010 | |
245 | 0 | 0 | |a Accounts in drug discovery |h [electronic resource] : |b case studies in medicinal chemistry / |c [edited by] Joel Barrish, Percy Carter, Robert Zahler. |
260 | |a Cambridge : |b Royal Society of Chemistry, |c [2010], ©2011. | ||
300 | |a 1 online resource. | ||
336 | |a text |b txt |2 rdacontent. | ||
337 | |a computer |b c |2 rdamedia. | ||
338 | |a online resource |b cr |2 rdacarrier. | ||
490 | 1 | |a RSC Drug Discovery ; |v 4. | |
505 | 0 | 0 | |t The discovery of the dipeptidyl peptidase-4 (DPP4) inhibitor Onglyza : |t from concept to market / |r Jeffrey A. Robl and Lawrence G. Hamann -- |t The discovery of Vorapaxar (SCH 530348), a thrombin receptor (protease activated receptor-1) antagonist with potent antiplatelet effects / |r Samuel Chackalamannil -- |t The discovery of Piragliatin, a glucokinase activator / |r Ramakanth Sarabu, Jefferson W. Tilley and Joseph Grimsby -- |t The discovery of OSI-906, a small-molecule inhibitor of the insulin-like growth factor-1 and insulin receptors / |r Mark J. Mulvihill and Elizabeth Buck -- |t The genesis of the antibody conjugate gemtuzumab ozogamicin (Mylotarg®) for acute myeloid leukemia / |r Philip R. Hamann -- |t Novel androgen receptor antagonists for the treatment of prostate cancer / |r Ashvinikumar V. Gavai, William R. Foster, Aaron Balog and Gregory D. Vite -- |t The discovery of UK-390957 : |t the challenge of targeting a short half-life, rapid Tmax SSRI / |r Mark D. Andrews and Donald S. Middleton -- |t The discovery of the long-acting PDE5 inhibitor PF-489791 for the treatment of pulmonary hypertension / |r Andrew S. Bell and Michael J. Palmer -- |t From HTS to market : |t the discovery and development of maraviroc, a CCR5 antagonist for the treatment of HIV / |r Chris Barber and David Pryde -- |t The discovery of GS-9131, an amidate prodrug of a novel nucleoside phosphate HIV reverse transcriptase inhibitor / |r Richard Mackman -- |t 2'-F-2'-C-methyl nucleosides and nucleotides for the treatment of hepatitis C virus : |t from discovery to the clinic / |r Michael J. Sofia, Phillip A. furman and William T. Symonds -- |t A case history on the challenges of central nervous system and dual pharmacology drug discovery / |r Paul V. Fish, Anthony Harrison, Florian Wakenhut and Gavin A. Whitlock -- |t The discovery of TRPV1 antagonists : |t turning up the heat / |r Mark H. Norman -- |t Uncoupling neuroprotection from immunosuppression : |t the discovery of ILS-920 / |r Edmund I. Graziani -- |t Identification of [alpha] 7 nicotinic acetylcholine receptor agonists for their assessment in improving cognition in schizophrenia / |r Bruce N. Rogers [and others] |
520 | |a Accounts in Drug Discovery describes recent case studies in medicinal chemistry with a particular emphasis on how the inevitable problems that arise during any project can be surmounted or overcome. The Editors cover a wide range of therapeutic areas and medicinal chemistry strategies, including lead optimization starting from high throughput screening ""hits"" as well as rational, structure-based design. The chapters include ""follow-ons"" and ""next generation"" compounds that aim to improve upon first generation agents. This volume surveys the range of challenges commonly faced by medicinal. | ||
588 | 0 | |a Online resource; title from title screen (viewed on June 15, 2010) | |
650 | 0 | |a Drug development |v Case studies. | |
650 | 0 | |a Pharmaceutical chemistry |v Case studies. | |
650 | 7 | |a Drug development. |2 fast |0 fst00898670 | |
650 | 7 | |a Pharmaceutical chemistry. |2 fast |0 fst01060115 | |
655 | 7 | |a Case studies. |2 fast |0 fst01423765 | |
700 | 1 | |a Barrish, Joel Charles, |d 1957- |0 http://id.loc.gov/authorities/names/n85809901 |1 http://isni.org/isni/0000000028720502. | |
700 | 1 | |a Carter, Percy. |0 http://id.loc.gov/authorities/names/n91023505 | |
700 | 1 | |a Zahler, Robert. | |
776 | 0 | 8 | |i Print version: |t Accounts in drug discovery. |d Cambridge : Royal Society of Chemistry, [2010], ©2011 |z 9781849731263 |z 1849731268 |w (OCoLC)671469689. |
856 | 4 | 0 | |u https://colorado.idm.oclc.org/login?url=https://doi.org/10.1039/9781849731980 |z Full Text (via RSC) |
830 | 0 | |a RSC drug discovery series ; |v 4. |0 http://id.loc.gov/authorities/names/no2010092643 | |
907 | |a .b121591931 |b 05-03-22 |c 04-19-22 | ||
915 | |a - | ||
998 | |a web |b 04-29-22 |c b |d b |e - |f eng |g enk |h 0 |i 1 | ||
907 | |a .b121591931 |b 05-02-22 |c 04-19-22 | ||
944 | |a MARS - RDA ENRICHED | ||
956 | |a RSC eBooks | ||
956 | |b RSC eBooks 2010 | ||
999 | f | f | |i 28573263-1311-5caf-895b-5505f5d1c5ff |s 06d392b0-a8c5-5dc2-9cbf-e876475a6d16 |
952 | f | f | |p Can circulate |a University of Colorado Boulder |b Online |c Online |d Online |e RM301.25 .A23 2010 |h Library of Congress classification |i web |n 1 |